Pulsenmore Ltd (PLSM) Return on Equity ROE from the fourth quarter 2025 to fourth quarter and annually, average high and low, overall ranking from Dec 31 2025 to - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Pulsenmore Ltd   (PLSM)

Pulsenmore Ltd 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Pulsenmore Ltd in the fourth quarter 2025?
Pulsenmore Ltd achieved a return on average equity (ROE) of 19.08 % in its fourth quarter 2025, this is above PLSM's average return on equity of 0%.
Pulsenmore Ltd shareholder's equity over the 12 months ending in its fourth quarter 2025 are valued at $26 million

ROE has advanced compared to 0% in the third quarter 2025, due to net income growth.

Within the Medical Equipment & Supplies industry Pulsenmore Ltd achieved the highest return on equity. While the total ranking for ROE unchanged, relative to the third quarter 2025 at no. .

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Equity Change -1.79 % - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 5 0 0 0 0
Return On Equity (TTM) 19.08 % 0 % 0 % 0 % 0 %
PLSM's Total Ranking # # # # #
Equity (TTM) in Millions 26 26 26 26 27
Seq. Equity Change 0 % 0 % 0 % -1.79 % -
Seq. Net Income Change - - - - -

Back to PLSM Management Effectiveness >> PLSM's 5 Years Annual ROE >> Compare PLSM ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





PLSM Annual Return On Equity (Dec 31 2025)
2025



Total Equity in Millions 26 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions -5 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity -19.08 % - - - -

Back to PLSM Management Effectiveness >> PLSM's 5 Years Annual ROE >> Compare PLSM ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
PLSM's' Return on Equity at Yahoo Finance
PLSM's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for PLSM's Competitors
Subscribers only: Roe for Pulsenmore Ltd 's Suppliers
Subscribers only: Return On Equity for PLSM's Customers




Companies with similar Return On Equity at Dec 31 2025, within Healthcare Sector ROE
Concentra Group Holdings Parent Inc   47.62 %
Theravance Biopharma inc   46.03 %
Galmed Pharmaceuticals Ltd   43.72 %
Acadia Pharmaceuticals Inc   41.90 %
Arrowhead Pharmaceuticals Inc   41.16 %
Gilead Sciences Inc   41.14 %
Tenet Healthcare Corp  40.89 %
Agilent Technologies inc   40.80 %
Gsk Plc  39.41 %
Bristol myers Squibb Company  39.17 %
Hutchmed china Limited  36.98 %
Oramed Pharmaceuticals Inc  36.81 %
Solventum Corporation  36.74 %
Newgenivf Group Limited  36.53 %
Merck and Co Inc   36.16 %
Adma Biologics Inc   34.98 %
Illumina Inc   34.94 %
Compugen Ltd  34.40 %
Vaxart Inc   33.83 %
Johnson and Johnson  33.78 %
Dexcom Inc   32.44 %
Phibro Animal Health Corporation  32.06 %
Innoviva Inc   30.60 %
Pro dex Inc   30.23 %
Novartis Ag  30.00 %
Incyte Corporation  29.15 %
Waters Corporation  28.52 %
Puma Biotechnology Inc   27.81 %
Resmed Inc   25.18 %
Encompass Health Corporation  24.76 %

Date modified: 2026-09-08T15:11:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.